Harvard Bioscience, Inc. announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth. The Company expects to realize overall annual run rate savings of approximately $4 million beginning in the second quarter of 2024. The Company also expects second quarter restructuring-related charges of approximately $0.5 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.265 USD | -0.15% | -4.81% | -38.97% |
May. 07 | Transcript : Harvard Bioscience, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $24.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.97% | 142M | |
+11.00% | 227B | |
+15.26% | 198B | |
+18.14% | 142B | |
+31.38% | 111B | |
+1.56% | 64.16B | |
+18.23% | 54.1B | |
+5.12% | 51.41B | |
+10.72% | 45.32B | |
+5.55% | 37.32B |
- Stock Market
- Equities
- HBIO Stock
- News Harvard Bioscience, Inc.
- Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth